Search results for " article"

showing 10 items of 6903 documents

New Insight into Immunity and Immunopathology of Rickettsial Diseases

2011

Human rickettsial diseases comprise a variety of clinical entities caused by microorganisms belonging to the generaRickettsia,Orientia,Ehrlichia, andAnaplasma. These microorganisms are characterized by a strictly intracellular location which has, for long, impaired their detailed study. In this paper, the critical steps taken by these microorganisms to play their pathogenic roles are discussed in detail on the basis of recent advances in our understanding of molecularRickettsia-host interactions, preferential target cells, virulence mechanisms, three-dimensional structures of bacteria effector proteins, upstream signalling pathways and signal transduction systems, and modulation of gene exp…

lcsh:Immunologic diseases. AllergySettore MED/09 - Medicina InternaVirulence FactorsRickettsial diseasesImmunologyRickettsiaceae InfectionsVirulenceImmunopathologyReview ArticleAdaptive ImmunityHost SpecificityMicrobiologyImmune systemBacterial ProteinsImmunityAnimalsHumansImmunology and AllergyAnaplasmaMolecular Targeted TherapyRickettsiaArthropodsPathogenRickettsieaeGeneticsImmunopathology; Rickettsial diseasesbiologyEffectorGeneral Medicinebacterial infections and mycosesbiology.organism_classificationAcquired immune systemOrientiaImmunity InnateGene Expression RegulationHost-Pathogen Interactionslcsh:RC581-607Signal TransductionClinical and Developmental Immunology
researchProduct

γδ T Cells Cross-Link Innate and Adaptive Immunity in Mycobacterium tuberculosis Infection

2011

Protective immunity against mycobacterial infections such asMycobacterium tuberculosisis mediated by interactions between specific T cells and activated antigen presenting cells. To date, many aspects of mycobacterial immunity have shown that innate cells could be the key elements that substantially may influence the subsequent adaptive host response. During the early phases of infection, innate lymphocyte subsets play a pivotal role in this context. Here we summarize the findings of recent investigations onγδT lymphocytes and their role in tuberculosis immunity.

lcsh:Immunologic diseases. AllergyT-LymphocytesT cellImmunologyReview ArticleAdaptive ImmunityLymphocyte ActivationMycobacterium tuberculosisImmune systemAntigenImmunitymedicineAnimalsHumansTuberculosisImmunology and AllergyIL-2 receptorAntigen-presenting cellbiologyReceptors Antigen T-Cell gamma-deltaMycobacterium tuberculosisGeneral MedicineAcquired immune systembiology.organism_classificationVirologyImmunity Innategamma delta T cells Mycobacterium tuberculosismedicine.anatomical_structureImmunologylcsh:RC581-607Immunologic Memory
researchProduct

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis

2014

With 1.4 million deaths and 8.7 million new cases in 2011, tuberculosis (TB) remains a global health care problem and together with HIV and Malaria represents one of the three infectious diseases world-wide. Control of the global TB epidemic has been impaired by the lack of an effective vaccine, by the emergence of drug-resistant forms of Mycobacterium tuberculosis (Mtb) and by the lack of sensitive and rapid diagnostics. It is estimated, by epidemiological reports, that one third of the world's population is latently infected with Mtb, but the majority of infected individuals develop long-lived protective immunity, which controls and contains Mtb in a T cell-dependent manner. Development o…

lcsh:Immunologic diseases. AllergyTuberculosisPopulationImmunologyReview ArticleDiseaseMycobacterium tuberculosis03 medical and health sciences0302 clinical medicineImmunitymedicineM. tuberculosiscytokineinfection.Immunology and AllergyCytotoxic T celleducationImmunodeficiency030304 developmental biologySettore MED/04 - Patologia Generale0303 health scienceseducation.field_of_studydiseasebiologybusiness.industrymedicine.diseasebiology.organism_classificationVirologyinfection3. Good healthhuman memory T cellsImmunologyCytokinesbusinesslcsh:RC581-607human memory T cellMalaria030215 immunologyM. tuberculosi
researchProduct

Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab

2015

International audience; Natalizumab (NTZ), a monoclonal antibody recognizing the alpha4 integrin chain, has been approved for the treatment of active multiple sclerosis, but expose to the onset of a rare side effect, progressive multifocal leukoencephalopathy (PML). Estimating the individual risk of PML in NTZ-treated patients is a major challenge, and therapeutic strategies are mainly guided by the overall PML risk assessed by identified risk factors: JC virus (JCV) seropositivity, treatment duration (with peak incidence after 24 months), and the previous use of immunosuppressive therapies. Given that this stratification does not yet allow a precise individual prediction of PML, other pred…

lcsh:Immunologic diseases. Allergy[SDV.IMM] Life Sciences [q-bio]/ImmunologySide effectmedicine.drug_classvirusesImmunologyJC virusReview Articlerisk stratificationCD11aJC virusmultiple sclerosismedicine.disease_causeMonoclonal antibodyCD49dprogressive multifocal leukoencephalopathyNatalizumabeffector memory T-cellst effector memory cellsImmunology and AllergyMedicineselectinPMLbusiness.industryMultiple sclerosisProgressive multifocal leukoencephalopathyvirus diseasesmedicine.disease3. Good healthJCVImmunologySelectins[SDV.IMM]Life Sciences [q-bio]/Immunologylcsh:RC581-607businessmedicine.drugFrontiers in Immunology
researchProduct

B lymphocyte intestinal homing in inflammatory bowel disease.

2011

Abstract Background Inflammatory bowel disease (IBD) is thought to be due to an abnormal interaction between the host immune system and commensal microflora. Within the intestinal immune system, B cells produce physiologically natural antibodies but pathologically atypical anti-neutrophil antibodies (xANCAs) are frequently observed in patients with IBD. The objective is to investigate the localisation of immunoglobulin-producing cells (IPCs) in samples of inflamed intestinal tissue taken from patients with IBD, and their possible relationship with clinical features. Methods The IPCs in small intestinal, colonic and rectal biopsy specimens of patients with IBD were analysed by means of immun…

lcsh:Immunologic diseases. AllergylymphocytesAdultMalePathologymedicine.medical_specialtyLymphocyteBiopsyImmunologyFluorescent Antibody TechniqueInflammatory bowel diseaseImmunophenotypingImmunomodulationImmune systemAntigens CDCell Movementinflammatory bowel diseasemedicineHumansB1 cells; Inflammation; Inflammatory bowel disease; Lymphocyte homing; Lymphocytes; Mucosal immunity; Adult; Aged; Antigens CD; B-Lymphocytes; Biopsy; Cell Differentiation; Cell Movement; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin M; Immunomodulation; Immunophenotyping; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Male; Middle Aged; ImmunologyIntestinal MucosaB cellAgedB-LymphocytesbiologyB1 cellsCell DifferentiationMiddle Agedmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisB-1 cellIntestinesmedicine.anatomical_structureImmunoglobulin MinflammationImmunologybiology.proteinmucosal immunityFemalelymphocyte homingCD5Antibodylcsh:RC581-607Research Article
researchProduct

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation

2008

AbstractBackgroundLeukotriene B4(LTB4) is a potent inflammatory mediator that also stimulates the immune response. In addition, it promotes polymorphonuclear leukocyte phagocytosis, chemotaxis, chemokinesis and modulates cytokines release. Regarding chemical instability of the leukotriene molecule, in the present study we assessed the immunomodulatory activities conferred by LTB4released from microspheres (MS). A previous oil-in-water emulsion solvent extraction-evaporation method was chosen to prepare LTB4-loaded MS.ResultsIn the mice cremasteric microcirculation, intraescrotal injection of 0.1 ml of LTB4-loaded MS provoked significant increases in leukocyte rolling flux, adhesion and emig…

lcsh:Immunologic diseases. Allergymedicine.medical_specialtyLeukotriene B4ImmunologyChemokinesisLeukocyte RollingBiologyPharmacologyNitric OxideLeukotriene B4Nitric oxideMicechemistry.chemical_compoundCell MovementInternal medicineCell AdhesionLeukocytesmedicineAnimalsHumansLeukocyte RollingPPAR alphaLungChemokine CCL2NitritesLeukotrieneMonocyteEndothelial CellsChemotaxisMicrospheresEndocrinologymedicine.anatomical_structurechemistryMacrophages Peritoneallipids (amino acids peptides and proteins)Cell activationlcsh:RC581-607Research ArticleBMC Immunology
researchProduct

Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development

2012

Advanced therapy medicinal products (ATMPs), including cell therapy products, form a new class of medicines in the European Union. Since the ATMPs are at the forefront of scientific innovation in medicine, specific regulatory framework has been developed for these medicines and implemented from 2009. The Committee for Advanced Therapies (CAT) has been established at the European Medicines Agency (EMA) for centralized classification, certification and evaluation procedures, and other ATMP-related tasks. Guidance documents, initiatives, and interaction platforms are available to make the new framework more accessible for small- and medium-sized enterprises, academia, hospitals, and foundation…

lcsh:Immunologic diseases. Allergymesenchymal stem/progenitor cellMesenchymal stem cells (MSC)ImmunologyReview ArticleCertificationBest interestsAgency (sociology)Hospital Exemption authorisationImmunology and AllergyMedicinemedia_common.cataloged_instanceProduct (category theory)European unionHospital Exemptionmedia_commonbusiness.industrynational competent authorityCommittee for Advanced TherapiesCell therapy medicinal product (CTMP)AuthorizationGuidance documentsCommittee for Advanced Therapies (CAT)Engineering managementNew product developmentadvanced therapy medicinal productlcsh:RC581-607businesscell therapy medicinal productAdvanced therapy medicinal product (ATMP)Frontiers in Immunology
researchProduct

Macrophage: SHIP of Immunity

2014

Immunology. Why does it exist? Two words. Cure disease. People get diseases. “Test tubes” do not. People fund immunologists for solutions to their health problems. But, immunologists often study leukocytes in test tubes – the laboratory – away from diseases. Why? Because much can be learned from analyzing cellular biochemistry and behaviors in vitro that cannot be ascertained when leukocytes are in animals. At the same time, isolated leukocyte reactions often do not reflect how the immune system operates as a unit. So, it is critical to verify in vitro observations in vivo. Among leukocytes, macrophages are the central initiating and directing element in immune systems, and serve this role …

lcsh:Immunologic diseases. AllergywoundImmunologyM1DiseasemacrophageBiologyM2Immune systemAntigenIn vivoImmunitynitric oxideImmunology and AllergyMacrophagecancerCancerWound HealingInnate immune systemMacrophagesarginaseOpinion ArticleIn vitroiNOSImmunologylcsh:RC581-607Frontiers in Immunology
researchProduct

Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture Systems

2019

The secretion of potential therapeutic factors by mesenchymal stem cells (MSCs) has aroused much interest given the benefits that it can bring in the field of regenerative medicine. Indeed, the in vitro multipotency of these cells and the secretive capacity of both angiogenic and immunomodulatory factors suggest a role in tissue repair and regeneration. However, during culture, MSCs rapidly lose the expression of key transcription factors associated with multipotency and self-renewal, as well as the ability to produce functional paracrine factors. In our study, we show that a three-dimensional (3D) culture method is effective to induce MSC spheroid formation, to maintain the multipotency an…

lcsh:Internal medicineAmnionArticle SubjectRegeneration (biology)Mesenchymal stem cellCell BiologyBiologyRegenerative medicineMicrovesiclesIn vitroCell biologyParacrine signallingmedicine.anatomical_structurehuman amnion-derived mesenchymal stem cellmedicinelcsh:RC31-1245Molecular BiologyTranscription factorResearch Article
researchProduct

Overweight Adolescents’ Self-Perceived Weight and Weight Control Behaviour: HBSC Study in Finland 1994–2010

2012

Introduction. Overweight and perception of being overweight, may lead adolescent to lose weight. The aim of the present study was to investigate overweight adolescents’ self-perceived weight, body dissatisfaction, and weight control behaviour during 1994–2010 in Finland.Methods. The country-representative, cross-sectional data of 15-year olds were obtained from the Health Behaviour in School-aged Children (HBSC) study, conducted in 1994 (; males: 48%), 1998 (; 49%), 2002 (; 50%), 2006 (; 47%), and 2010 (; 48%).Results. The majority of overweight boys (62–69%) and girls (89–100%) assessed themselves as too fat, and their body image was lower than in nonoverweight adolescents. The highest pre…

lcsh:Internal medicinePediatricsmedicine.medical_specialtyArticle Subjectbusiness.industryEndocrinology Diabetes and MetabolismSignificant differenceHealth behaviourylipainoOverweightWeight control behaviournuoretself-perceived weightylipainoisuuslihavuusMedicineSelf perceivedkoettu painoadolescentsmedicine.symptomlcsh:RC31-1245businessResearch ArticleBody dissatisfactionDemographyJournal of Obesity
researchProduct